| Literature DB >> 16623958 |
Ava Grace Tan1, Jie Jin Wang, Elena Rochtchina, Paul Mitchell.
Abstract
BACKGROUND: In this study, we aimed to compare age-specific cortical, nuclear and posterior subcapsular (PSC) cataract prevalence in two surveys 6 years apart.Entities:
Mesh:
Year: 2006 PMID: 16623958 PMCID: PMC1524813 DOI: 10.1186/1471-2415-6-17
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Participant characteristics.
| Characteristics | Cross-section I | Cross-section II | ||
| n | % | n | % | |
| Age (mean) | (66.2) | (66.7) | ||
| 50–54 | 485 | 13.3 | 350 | 10.0 |
| 55–59 | 534 | 14.6 | 580 | 16.5 |
| 60–64 | 638 | 17.5 | 600 | 17.1 |
| 65–69 | 671 | 18.4 | 639 | 18.2 |
| 70–74 | 538 | 14.7 | 572 | 16.3 |
| 75–79 | 422 | 11.6 | 407 | 11.6 |
| 80–84 | 230 | 6.3 | 226 | 6.4 |
| 85–89 | 100 | 2.7 | 110 | 3.1 |
| 90+ | 36 | 1.0 | 24 | 0.7 |
| Female | 2072 | 56.7 | 1998 | 57.0 |
| Ever Smokers | 1784 | 51.2 | 1789 | 51.2 |
| Use of inhaled steroids | 370 | 10.94 | 478 | 13.8^ |
| History of: | ||||
| Diabetes | 284 | 7.8 | 347 | 9.9^ |
| Hypertension | 1669 | 46.0 | 1825 | 52.2^ |
| Emmetropia* | 1558 | 42.9 | 1478 | 42.2 |
| Myopia* | 442 | 12.2 | 495 | 14.1^ |
| Hyperopia* | 1633 | 45.0 | 1532 | 43.7 |
n = number of persons affected
* best spherical equivalent refraction correction
^ P < 0.01
Figure 1Cataract prevalence in cross-sections I and II of the Blue Mountains Eye Study.
Age-specific prevalence of cataract types in cross sections I and II.
| Cataract type | Age (years) | Cross-section I | Cross-section II | ||
| n | % (95% CL)* | n | % (95% CL)* | ||
| Cortical | 50–54 | 473 | 4.4 (2.6–6.3) | 338 | 7.4 (4.6–10.2) |
| 55–59 | 522 | 9.2 (6.7–11.7) | 542 | 9.0 (6.6–11.5) | |
| 60–64 | 615 | 16.4 (13.5–19.4) | 556 | 16.7 (13.6–19.8) | |
| 65–69 | 653 | 26.2 (22.8–29.6) | 581 | 23.6 (20.1–27.0) | |
| 70–74 | 516 | 31.2 (27.2–35.2) | 514 | 35.4 (31.3–39.6) | |
| 75–79 | 366 | 40.2 (35.1–45.2) | 332 | 39.8 (34.5–45.1) | |
| 80–84 | 194 | 58.8 (51.8–65.8) | 163 | 42.9 (35.3–50.6) | |
| 85–89 | 74 | 52.7 (41.1–64.4) | 73 | 54.8 (43.1–66.5) | |
| 90+ | 22 | 68.2 (47.0–89.3) | 14 | 78.6 (54.0–103.2) | |
| PSC | 50–54 | 474 | 2.7 (1.3–4.2) | 338 | 2.4 (0.7–4.0) |
| 55–59 | 522 | 2.9 (1.4–4.3) | 541 | 2.6 (1.3–3.9) | |
| 60–64 | 616 | 4.6 (2.9–6.2) | 548 | 5.7 (3.7–7.6) | |
| 65–69 | 655 | 6.3 (4.4–8.1) | 573 | 4.5 (2.8–6.3) | |
| 70–74 | 517 | 6.8 (4.6–8.9) | 505 | 9.7 (7.1–12.3) | |
| 75–79 | 367 | 11.4 (8.2–14.7) | 327 | 9.5 (6.3–12.7) | |
| 80–84 | 196 | 12.2 (7.6–16.9) | 155 | 10.3 (5.5–15.2) | |
| 85–89 | 74 | 18.9 (9.8–28.1) | 69 | 11.6 (3.9–19.4) | |
| 90+ | 23 | 21.7 (3.5–40.0) | 11 | 0.0 | |
| Nuclear | 50–54 | 323 | 1.6 (0.2–2.9) | 331 | 0.9 (–0.2–1.9) |
| 55–59 | 386 | 2.3 (0.8–3.8) | 507 | 3.6 (1.9–5.2) | |
| 60–64 | 453 | 5.3 (3.2–7.4) | 501 | 11.6 (8.8–14.4) | |
| 65–69 | 478 | 17.2 (13.8–20.1) | 534 | 18.5 (15.2–21.9) | |
| 70–74 | 392 | 27.6 (23.1–32.0) | 453 | 36.0 (31.6–40.4) | |
| 75–79 | 255 | 45.1 (39.0–51.3) | 302 | 55.6 (50.0–61.3) | |
| 80–84 | 146 | 54.1 (45.9–62.3) | 147 | 73.5 (66.3–80.7) | |
| 85–89 | 50 | 64.0 (50.2–77.8) | 70 | 80.0 (70.4–89.6) | |
| 90+ | 18 | 72.2 (49.3–95.1) | 15 | 73.3 (48.0–98.7) | |
n = number of persons
* 95% Confidence Limits
Gender distribution of cataract types in cross-sections I and II.
| Cataract type | Gender | Cross-section I | Cross-section II | ||
| n | % (95% CL)* | n | % (95% CL)* | ||
| Cortical | Male | 1496 | 21.1 (19.0–23.1) | 1328 | 20.4 (18.2–22.6) |
| Female | 1939 | 25.9 (23.9–27.8) | 1785 | 26.2 (24.2–28.3) | |
| PSC | Male | 1500 | 6.5 (5.2–7.7) | 1314 | 6.4 (5.1–7.7) |
| Female | 1944 | 6.2 (5.1–7.2) | 1753 | 5.7 (4.6–6.7) | |
| Nuclear | Male | 1106 | 17.6 (15.4–19.9) | 1225 | 22.5 (20.1–24.8) |
| Female | 1395 | 19.5 (17.4–21.6) | 1635 | 25.0 (22.9–27.1) | |
n = number of persons
* 95% Confidence Limits